An electrode and method of making same characterized by a biological material used as a substrate. The electrode is used primarily as a stimulation electrode, but could also be used to monitor electrical activity of neural tissues. The biological substrate is a chronically implantable material of treaterd human or animal tissue. The use of this material tends to prevent undue fibrosis and necrosis of the nerve tissue. An inner layer of a non-biologic dielectric may be used to increase to resistivity of the structure. Similarly an inner layer of shielding material may also be used.

Patent
   5031621
Priority
Dec 06 1989
Filed
Dec 06 1989
Issued
Jul 16 1991
Expiry
Dec 06 2009
Assg.orig
Entity
Large
61
9
all paid
5. A method of making an electrode comprising:
a. making a substrate by treating a plurality of layers of a biological material for chronic implantation;
b. placing a layer of a non-biological material between said plurality of layers of said biological material;
c. fixedly attaching a conductor to a side of said substrate; and,
d. electrically coupling a lead to said conductor.
1. An electrode comprising:
a. a substrate of a plurality of layers of a treated biological material wherein at least a first of said plurality of layers is separated from a second of said plurality of layers by a third layer of a material different from said treated biological material;
b. a conducting surface attached to said substrate; and,
c. a lead electrically coupled to said conducting surface.
2. An electrode according to claim 1 wherein said third layer comprises a non-biological insulator of high dielectric constant.
3. An electrode according to claim 2 wherein said substrate further comprises a fourth layer of shielding material located between said plurality of layers of said treated biological material.
4. An electrode according to claim 1 wherein said third layer comprises a layer of shielding material.

1. Field of the Invention

The present invention relates generally to electrode systems for stimulation or monitoring electrical activity in nerve tissue and more particularly relates to chronically implantable electrodes.

2. Description of the Prior Art

The use of electrodes to monitor electrical activity and stimulate body tissue is quite old. R. H. Wappler U.S. Pat. No. 1,662,446 teaches an early electrode system. The Wappler electrode is used for acute stimulation only, and is not implantable.

An early stimulation electrode which is chronically implantable is taught by S. I Schwartz, et al. in U.S. Pat. No. 3,421,511. Hagfors U.S. Pat. No. 3,654,933 teaches an improved stimulation electrode for chronic implantation.

Testerman U.S. Pat. No. 4,341,221 teaches an improved electrode for chronic implantation. The Testerman electrode is suitable for monitoring electrical activity in nerve tissue. This electrode uses a substrate of silicone rubber or other material which is inert when chronically implanted. However, as with the other electrodes, the Testerman electrode does not prevent excess fibrotic growth.

The present invention produces a chronically implantable electrode suitable for stimulation or monitoring of electrical activity in nerve tissue This electrode uses a substrate of biological tissue which has been properly treated to ensure long term resistance to excess fibrotic growth. An electrically conductive surface is fixedly attached to one side of the substrate. This side becomes the inside as the flexible substrate is wrapped about the nerve to be monitored. The resistivity of the biological tissue is used to electrically insulate the exposed nerve tissue and electrically conductive surface in contact therewith. An electrically insulated conductor couples the electrically conductive surface with electronic circuitry.

For those applications requiring greater resistivity than the substrate can provide, additional layers can be added. Alternatively, a non-biological insulator of high dielectric constant can be interposed between two layers of the biologic material for increased resistivity.

A layer of a flexible conducting material may also be added between layers of the biological material to provide electrostatic and electromagnetic shielding. This shielding material may be grounded as necessary.

Other features of the present invention and many of the attendant advantages will be readily appreciated as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, in which like reference numerals designate like parts throughout the figures thereof and wherein:

FIG. 1 is a plan view of an electrode of the present invention in position to be wrapped about a nerve;

FIG. 2 is a cross sectional cut away view of the layers of an alternate embodiment;

FIG. 3 is a cross sectional cut away view of the layers of a second alternative embodiment; and,

FIG. 4 is a plan view of an electrode of the present invention as chronically implanted.

FIG. 1 is a plan view of an electrode 10 of the present invention placed in proximity to a nerve 30. The electrode 10 has a substrate 12 to which is attached conductor 50 on one side 20. Conductor 50 is configured as a coil or other geometric shape which provides the desired surface area. Conductor 50 is electrically coupled to the distal end of insulated lead 40. The proximal end of lead 40 is coupled to electronic monitoring circuitry which is not shown.

Substrate 12 is of a sufficient size to conveniently wrap about nerve 30 with enough surface area to easily suture into place, without being so large as to be difficult to manage. Substrate 12 may be of a single layer as shown in this embodiment. It is made of a biological material which has been treated to enhance chronic implantability. A preferred material is porcine pericardium, although other biological materials may be used. The biological material is treated with a fixant such as glutaraldehyde.

The insulating properties of the resulting substrate 12 are moderate. Therefore, it may be desirable to use multiple layers of the biological material. A limitation of the use of such auxiliary layers is the desirability of a small and flexible substrate 12.

FIG. 2 is a cut away cross sectional view of an alternative embodiment of substrate -4. This embodiment provides greater resistivity with less bulk than can be achieved with multiple layers of biological material. In this embodiment, layers 22 and 24 are of the biological material. They are positioned on the exterior surfaces of substrate 14 to ensure that only the biological material is in contact with nerve 30 and other living body tissue.

Located between layers 22 and 24 is insulating material 26. This may be, without limitation, silicone rubber or other flexible material of high dielectric constant. Because insulating material 26 should be chosen of a chronically implantable material, it need not be covered at the edges by the biological material. However, it is desirable to cover all of insulating material 26 to discourage any unnecessary fibrotic growth.

FIG. 3 is a cut away cross sectional view of a second alternative embodiment of substrate 16. Layers 22 and 24 are of the biological material as described in the embodiment of FIG. 2. Similarly, insulating layer 26 consists of the chronically implantable material of high dielectric constant of that embodiment. Layer 27 is a thin flexible metallic layer of a light conductive material. It is preferably of a biocompatible material, such as platinum, as a safety precaution. It also enables the substrate 16 to leave the edges of layer 27 uncovered by any of layers 22, 24, or 26 although it is desirable to do so as explained above.

Layer 27 provides shielding of the electrical interface between nerve 30 and conductor 50. This shielding attenuates electrostatic and electromagnetic noise in the environment. Alternatively, layer 27 may be electrically coupled to ground as is appropriate.

FIG. 4 is a plan view of the electrode 10 as chronically implanted. This particular implantation technique is considered as representative only and should not be construed as limiting of the present invention. Those skilled in the art will readily be able to apply the present invention to other modes of implantation. Substrate 12 is wrapped about nerve 30 as shown. Permanent attachment is accomplished by creating excess flap 28 and applying sutures 29 as shown. The mechanical coupling of the distal end of insulating lead 40 to substrate 12 is sealed using medical adhesive 60.

Having thus described the preferred embodiments of the present invention, those of skill in the art will be readily able to apply the teachings found herein to other embodiments without departing from the scope of the claims hereto attached.

Grandjean, Pierre A., Lee, Philip H. J.

Patent Priority Assignee Title
10016600, May 30 2013 NEUROSTIM SOLUTIONS, LLC Topical neurological stimulation
10188854, Jun 09 2009 NEURONANO AB Microelectrode and multiple microelectrodes
10307591, May 30 2013 NEUROSTIM SOLUTIONS, LLC Topical neurological stimulation
10314725, Nov 13 2014 The Regents of the University of Michigan Method for amplifying signals from individual nerve fascicles
10363411, Jun 09 2009 NEURONANO AB Microelectrode and multiple microelectrodes
10779963, Nov 13 2014 The Regents of the University of Michigan System for amplifying signals from individual nerve fascicles
10918853, May 30 2013 NEUROSTM SOLUTIONS, LLC Topical neurological stimulation
10946185, May 30 2013 NEUROSTIM SOLUTIONS LLC Topical neurological stimulation
10953225, Nov 07 2017 NEUROSTIM OAB, INC Non-invasive nerve activator with adaptive circuit
10994130, Sep 06 2016 BIOCIRCUIT TECHNOLOGIES, INC Devices and methods for repairing damage to a nerve
11077301, Feb 21 2015 NEUROSTIM OAB, INC Topical nerve stimulator and sensor for bladder control
11167131, Sep 06 2016 BioCircuit Technologies, Inc.; Virginia Commonwealth University Devices and methods for repairing damage to a tissue
11229789, May 30 2013 NEUROSTIM OAB, INC Neuro activator with controller
11291828, May 30 2013 NEUROSTIM SOLUTIONS LLC Topical neurological stimulation
11458311, Jun 26 2019 NEUROSTIM TECHNOLOGIES LLC Non-invasive nerve activator patch with adaptive circuit
11730958, Dec 16 2019 NEUROSTIM SOLUTIONS, LLC Non-invasive nerve activator with boosted charge delivery
5741319, Jan 27 1995 Medtronic, Inc Biocompatible medical lead
7460904, Oct 09 2002 WAKE FOREST UNIVERSITY HEALTH SCIENCES Wireless systems and methods for the detection of neural events using onboard processing
7536227, Jan 26 2005 Pacesetter, Inc. Shielded electrode for nerve sensing
7627373, Nov 30 2002 Cardiac Pacemakers, Inc Method and apparatus for cell and electrical therapy of living tissue
7751880, Feb 12 2007 Pacesetter, Inc.; Pacesetter, Inc Shielded electrode assembly for effective nerve sensing and stimulation
7764995, Jun 07 2004 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
7813812, Sep 27 2000 CVRX, INC Baroreflex stimulator with integrated pressure sensor
7840263, Feb 27 2004 Cardiac Pacemakers, Inc Method and apparatus for device controlled gene expression
7840271, Sep 27 2000 CVRx, Inc. Stimulus regimens for cardiovascular reflex control
7949400, Sep 27 2000 CVRX, INC Devices and methods for cardiovascular reflex control via coupled electrodes
7981065, Dec 20 2004 Cardiac Pacemakers, Inc Lead electrode incorporating extracellular matrix
8005526, Aug 31 2005 The Regents of the University of Michigan Biologically integrated electrode devices
8019401, Dec 04 2006 MGI MEDICAL, LLC Stretchable electrode and method of making physiologic measurements
8060206, Sep 27 2000 CVRX, INC Baroreflex modulation to gradually decrease blood pressure
8060219, Dec 20 2004 Cardiac Pacemakers, Inc Epicardial patch including isolated extracellular matrix with pacing electrodes
8086314, Sep 27 2000 CVRX, INC Devices and methods for cardiovascular reflex control
8290595, Oct 29 2002 CVRX, INC Method and apparatus for stimulation of baroreceptors in pulmonary artery
8583236, Mar 27 2002 CVRx, Inc. Devices and methods for cardiovascular reflex control
8606359, Sep 27 2000 CVRX, INC System and method for sustained baroreflex stimulation
8712531, Sep 27 2000 CVRx, Inc. Automatic baroreflex modulation responsive to adverse event
8718789, Sep 27 2000 CVRx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
8751014, Aug 25 2010 NEURONANO AB Displacement resistant microelectrode, microelectrode bundle and microelectrode array
8838246, Sep 27 2000 CVRX, INC Devices and methods for cardiovascular reflex treatments
8874204, Dec 20 2004 Cardiac Pacemakers, Inc Implantable medical devices comprising isolated extracellular matrix
8880190, Sep 27 2000 CVRx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
8903509, Mar 21 2012 Cardiac Pacemakers Inc. Systems and methods for stimulation of vagus nerve
8936794, Aug 25 2006 The Regents of the University of Michigan Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules
8954142, Jun 09 2009 NEURONANO AB Microelectrode and multiple microelectrodes
8954167, May 26 2009 Cardiac Pacemakers, Inc. Helically formed coil for a neural cuff electrode
8983626, Dec 28 2012 Cardiac Pacemarkers, Inc. Stimulation cuff and implantation tool
8996114, Jun 28 2011 Cardiac Pacemakers, Inc. Strain relief feature for an implantable medical device lead
9044347, May 02 2008 The Regents of the University of Michigan Hybrid bioelectrical interface device
9044609, Sep 27 2000 CVRx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
9050472, Sep 15 2010 Cardiac Pacemakers, Inc.; Cardiac Pacemakers, Inc Automatic selection of lead configuration for a neural stimulation lead
9084546, Aug 31 2005 The Regents of the University of Michigan Co-electrodeposited hydrogel-conducting polymer electrodes for biomedical applications
9114250, Oct 02 2012 Cardiac Pacemakers, Inc. Pinch to open cuff electrode
9283379, Oct 02 2012 Cardiac Pacemakers, Inc. Pinch to open cuff electrode
9320889, Feb 13 2013 Cardiac Pacemakers, Inc. Cuff electrode with integrated tendril
9352146, Jan 14 2011 The Regents of the University of Michigan Peripheral nerve interface devices for treatment and prevention of neuromas
9427583, Sep 27 2000 CVRx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
9452283, Feb 13 2013 Cardiac Pacemakers, Inc. Cuff electrode with integrated tendril
9533140, Jun 09 2009 NEURONANO AB Microelectrode and multiple microelectrodes
9731135, Sep 15 2010 Cardiac Pacemakers, Inc. Automatic selection of lead configuration for a neural stimulation lead
9808616, Jan 14 2011 The Regents of the University of Michigan Regenerative peripheral nerve interface
9878147, Jun 09 2009 NEURONANO AB Microelectrode and multiple microelectrodes
Patent Priority Assignee Title
3421511,
3654933,
3774618,
4258724, Apr 19 1978 Synthelabo Endocavitary cardiac stimulation probe
4341221, Oct 07 1980 Medtronic, Inc. Shielded recording electrode system
4628944, Feb 08 1982 Pacesetter, Inc Cardiac pacing lead with biodegradable fixation structure
4852573, Dec 04 1987 Implantable neural electrode
4928689, May 15 1989 Cardiac Pacemakers, Inc. Rate adaptive cardiac pacer system having living cell tissue for sensing physiologic demand
4940065, Jan 23 1989 Regents of the University of California Surgically implantable peripheral nerve electrode
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 18 1989GRANDJEAN, PIERRE A Medtronic, IncASSIGNMENT OF ASSIGNORS INTEREST 0052030608 pdf
Dec 18 1989LEE, PHILIP H J Medtronic, IncASSIGNMENT OF ASSIGNORS INTEREST 0052030608 pdf
Date Maintenance Fee Events
Dec 30 1994M183: Payment of Maintenance Fee, 4th Year, Large Entity.
May 23 1995ASPN: Payor Number Assigned.
Dec 29 1998M184: Payment of Maintenance Fee, 8th Year, Large Entity.
Dec 30 2002M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Jul 16 19944 years fee payment window open
Jan 16 19956 months grace period start (w surcharge)
Jul 16 1995patent expiry (for year 4)
Jul 16 19972 years to revive unintentionally abandoned end. (for year 4)
Jul 16 19988 years fee payment window open
Jan 16 19996 months grace period start (w surcharge)
Jul 16 1999patent expiry (for year 8)
Jul 16 20012 years to revive unintentionally abandoned end. (for year 8)
Jul 16 200212 years fee payment window open
Jan 16 20036 months grace period start (w surcharge)
Jul 16 2003patent expiry (for year 12)
Jul 16 20052 years to revive unintentionally abandoned end. (for year 12)